REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,540.00
Bid: 4,500.00
Ask: 4,540.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.889%)
Open: 4,580.00
High: 4,580.00
Low: 4,500.00
Prev. Close: 4,520.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Duncan Lawrie

19 Dec 2016 07:00

RNS Number : 2000S
Camellia PLC
19 December 2016
 

 

19 December 2016

 

Camellia Plc

 

Duncan Lawrie Private Bank ("Duncan Lawrie") - Update on Duncan Lawrie, sale of loan book and sale of Duncan Lawrie Asset Management

 

 

As highlighted in the recent interim report, lower interest rates and other factors have changed the outlook for private banking. This, coupled with its conservative risk appetite and opportunities for investment elsewhere in the group, has led Camellia Plc (the "Group") to review its earlier decision to invest further in Duncan Lawrie and it has therefore now decided to sell most of the Duncan Lawrie businesses.

The majority of Duncan Lawrie's UK loans and certain of its Isle of Man loans (the "Loan Book") have been sold to Arbuthnot Latham & Co. Limited for a cash consideration of £42.7 million, which equates to 95% of the value of the outstanding loans of £44.9 million. A subsequent orderly wind down of Duncan Lawrie's deposit taking and other banking operations in the UK and Isle of Man is proposed. Following this sale, Duncan Lawrie is fully funded to return all cash balances to clients.

Duncan Lawrie has also reached an agreement, subject to regulatory approval, to sell Duncan Lawrie Asset Management Limited to Brewin Dolphin Limited ("Brewin Dolphin"), a subsidiary of Brewin Dolphin Holdings Plc, for a cash consideration of £28.0 million.

Brewin Dolphin is one of the UK's leading discretionary wealth managers with over £35bn of funds under management and a long-term commitment to the market. As part of the transaction, the portfolio management team of Duncan Lawrie Asset Management Limited will move to Brewin Dolphin, providing continuity of service for clients and access to Brewin Dolphin's broader investment management and financial planning offering.

Camellia believes that both purchasers share the same high regard for client service as Duncan Lawrie and that in agreeing these sales, this should mitigate, as far as possible, the impact of these changes on clients and staff.

Discussions are underway with a number of other parties in respect of the sale of Duncan Lawrie's Isle of Man offshore trust services business.

The proceeds from these disposals will be used to repay depositors, meet any other liabilities of Duncan Lawrie and for investment in other parts of the Group.

The trading profits relating to the Loan Book in the year ending 31 December 2015 were £1.3 million and £0.8 million in the six months to 30 June 2016. The trading profits relating to Duncan Lawrie Asset Management in the year ending 31 December 2015 were £2.2 million and £0.6 million in the six months to 30 June 2016. These figures include costs which are not being transferred to the purchaser. The losses before taxation relating to the whole of Duncan Lawrie for the year ended 31 December 2015 were £3.6 million and £2.8 million in the six months to 30 June 2016.

The loss arising on sale of the Loan Book and significant closure costs of any proposed wind-down of Duncan Lawrie will be reflected in Camellia's financial results for the year ended 31 December 2016. The expected profit on disposal of Duncan Lawrie Asset Management and further operating costs relating to the proposed wind down will be reflected in Camellia's financial results for the year ended 31 December 2017.

Terms of the Loan Book sale

£34.7 million of the consideration is payable on completion today, with the balance of £8.0 million payable following novation or assignment of certain loan agreements which is expected to occur on 31 January 2017 ("Migration"). The consideration is subject to various adjustments on and shortly after Migration for loan repayments, advances and debt servicing costs in the period between 31 October 2016 and Migration.

Terms of the Duncan Lawrie Asset Management sale

Duncan Lawrie has agreed, subject to regulatory approval, to sell its wealth management business, Duncan Lawrie Asset Management Limited, but will retain the liabilities relating to the business, for £28.0 million payable at completion. The consideration is subject to a working capital adjustment.

This announcement contains inside information for the purpose of Article 7 of the Market Abuse Regulation (EU) N0. 596/2014

 

 

For further information:

 

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Fenchurch Advisory Partners LLP 020 7382 2222

Financial Adviser on the Duncan Lawrie Asset Management sale

Richard Locke

KPMG 020 7311 1000

Financial Adviser on the Loan Book sale

Andrew Jenke

Arun Sharma

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Andrew Godber

Erik Anderson

 

Maitland

William Clutterbuck 020 7379 5151

 

 

Fenchurch Advisory Partners LLP ("Fenchurch"), which is authorised and regulated by the FCA, is acting exclusively for Camellia plc and no-one else in connection with the sale of Duncan Lawrie Asset Management Limited and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Fenchurch nor for providing advice in relation to the sale of Duncan Lawrie Asset Management Limited or any other matters referred to in this announcement.

 

KPMG LLP, which is authorised and regulated in the UK by the FCA for investment business activities, is acting exclusively for Duncan Lawrie Holdings Limited (a subsidiary of Camellia plc) and no-one else in connection with the sale of the Loan Book and will not be responsible to anyone other than Duncan Lawrie Holdings Limited for providing the protections afforded to clients of KPMG LLP nor for providing advice in relation to the sale of the Loan Book or any other matters referred to in this announcement.

 

Panmure Gordon (UK) Limited is authorised and regulated in the United Kingdom by the FCA. Panmure Gordon (UK) Limited is acting as nominated adviser exclusively for Camellia plc and no one else in connection with the Disposals (as defined herein) and will not regard any other person as its client in relation to the Disposals and will not be responsible to anyone other than Camellia plc for providing the protections afforded to clients of Panmure Gordon (UK) Limited, nor for providing advice in relation to any matter referred to herein.

 

Forward looking statements

This announcement (including information incorporated by reference in this announcement), oral statements made regarding the sale of the Loan Book and of Duncan Lawrie Asset Management Limited (the "Disposals"), and other information published by Camellia plc contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Camellia plc about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements.

The forward-looking statements contained in this announcement include statements relating to the expected effects of the Disposals on Camellia plc, the expected timing and scope of the Disposals and other statements other than historical facts. Often, but not always, forward-looking statements can be identified by the use of forward-looking words such as "plans", "expects" or "does not expect", "is expected", "is subject to", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. Although Camellia plc believes that the expectations reflected in such forward-looking statements are reasonable, Camellia plc can give no assurance that such expectations will prove to be correct. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. Neither Camellia plc nor any of its associates or directors, officers or advisers, provides any representation, assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements in this announcement will actually occur. You are cautioned not to place undue reliance on these forward-looking statements. Other than in accordance with their legal or regulatory obligations, Camellia plc is not under any obligation, and Camellia plc expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISQKLBFQLFZFBF
Date   Source Headline
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc
8th Oct 20205:15 pmRNSUpdate on African allegations
7th Oct 202011:00 amRNSDirector/PDMR Shareholding
25th Sep 20209:58 amRNSInterim Report 2020
25th Sep 20207:00 amRNSHalf-year Report
15th Sep 202010:53 amRNSNotice of Interim Results
17th Aug 20201:55 pmRNSAsset Disposal Amendment
17th Aug 202011:17 amRNSAsset Disposal
10th Jun 20201:03 pmRNSCorrection to Result of AGM
10th Jun 202012:24 pmRNSResult of AGM
10th Jun 202011:30 amRNSAGM Trading Statement
15th May 202011:00 amRNSAnnual Report and Notice of Annual General Meeting
7th May 20203:18 pmRNSFinal Results
27th Apr 20207:00 amRNSTrading update
1st Apr 202012:00 pmRNSTrading update
26th Mar 20204:37 pmRNSPrice Monitoring Extension
6th Mar 20207:00 amRNSDirectorate Changes
21st Jan 20207:00 amRNSTrading Update
15th Aug 201910:51 amRNSInterim Report 2019
15th Aug 20197:00 amRNSHalf-year Report
7th Jun 201911:00 amRNSResult of AGM
6th Jun 201911:30 amRNSAGM Trading Statement
15th Apr 201912:13 pmRNSAnnual Report and Notice of AGM
11th Apr 20197:00 amRNSFinal Results
21st Mar 20194:40 pmRNSSecond Price Monitoring Extn
21st Mar 20194:35 pmRNSPrice Monitoring Extension
4th Dec 20187:00 amRNSTrading update
23rd Oct 20187:00 amRNSTrading Update
29th Aug 201811:40 amRNSInterim Report 2018
24th Aug 20187:00 amRNSHalf-year Report
8th Jun 201812:20 pmRNSResult of AGM
7th Jun 201811:30 amRNSAGM Trading Statement
25th Apr 20184:00 pmRNSAnnual Report and Notice of AGM
20th Apr 20181:57 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSFinal Results
21st Mar 20187:00 amRNSNotice of Results
22nd Dec 20179:42 amRNSDirectorate Change
6th Dec 201712:28 pmRNSTrading Statement
14th Nov 20173:00 pmRNSHolding(s) in Company
29th Aug 20173:20 pmRNSInterim report 2017
25th Aug 20177:00 amRNSHalf-year Report
2nd Jun 20171:13 pmRNSResult of AGM
1st Jun 201711:30 amRNSAGM Statement
11th May 20177:00 amRNSUpdate on Duncan Lawrie
2nd May 20172:05 pmRNSAnnual Financial Report
27th Apr 20177:00 amRNSFinal Results
21st Apr 20175:03 pmRNSUpdate on Duncan Lawrie
19th Dec 20167:00 amRNSUpdate on Duncan Lawrie
22nd Nov 20165:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.